Hospital end users ranked the CVIS and hemodynamic systems they use, shedding light on their working relationships with IT vendors. 

The VIRTUE and POLARIS studies are both focused on evaluating how the Varipulse PFA Platform performs in a variety of clinical scenarios. 

Scot Pollard has a long family history of heart disease, and he’s been on a watch list for several years now due to his size. He's been in and out of hospitals for more than three years due to an ongoing fight with cardiomyopathy. 

Remote monitoring with the Reveal Linq insertable cardiac monitor can improve outcomes without breaking the bank, according to new data being presented at the International Stroke Conference in Phoenix.

ASNC President Lawrence Phillips, MD, wants to see nuclear cardiologists modernize their labs and embrace new strategies for the evaluation of amyloidosis, sarcoidosis and inflammation.

These new guidelines provide a fresh look at topics ASE has not addressed with official society recommendations in many years. 

Back in October, a mobile cardiac imaging provider and its CEO agreed to pay $85 million to settle allegations they had participated in a kickback scheme. This latest DOJ complaint focuses on a former executive not named in that initial settlement. 

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.